These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients. Mamo DC, Sweet RA, Mulsant BH, Pollock BG, Miller MD, Stack JA, Begley AE, Reynolds CF. Am J Geriatr Psychiatry; 2000 Feb 08; 8(3):226-31. PubMed ID: 10910421 [Abstract] [Full Text] [Related]
13. Paroxetine treatment of trichotillomania in an adolescent. Block C, West SA, Baharoglu B. J Child Adolesc Psychopharmacol; 1998 Feb 08; 8(1):69-71. PubMed ID: 9639081 [Abstract] [Full Text] [Related]
15. Comparative efficacies of fluoxetine and paroxetine in major depression across varying acute-phase treatment periods: a meta-analysis. Wang Y, Yu L, Xie J, Chen J, Wei Q. Asia Pac Psychiatry; 2014 Dec 08; 6(4):353-62. PubMed ID: 24150924 [Abstract] [Full Text] [Related]
16. [Reaction on 'Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines']. Moleman P. Tijdschr Psychiatr; 2010 Dec 08; 52(11):801-2; author reply 802-4. PubMed ID: 21064023 [No Abstract] [Full Text] [Related]
19. Deciding which selective serotonin reuptake inhibitor to prescribe. Cleare AJ. BMJ; 1995 Dec 16; 311(7020):1641. PubMed ID: 8555826 [No Abstract] [Full Text] [Related]
20. Psychopharmacological treatment of major depressive disorder in children and adolescents. Varley CK. JAMA; 2003 Aug 27; 290(8):1091-3. PubMed ID: 12941683 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]